Back to Results
First PageMeta Content
Amyotrophic lateral sclerosis / SOD1 / Neurodegeneration / Neuroscience / Sean F. Scott / James Heywood / Rare diseases / ALS Therapy Development Institute / Health


Microsoft Word - TDP43 Collaboation[removed]
Add to Reading List

Document Date: 2011-06-07 11:14:18

Open Document

File Size: 135,64 KB

Share Result on Facebook

City

CAMBRIDGE / /

Company

ALS TDI / /

Currency

USD / /

/

Facility

Washington University / About ALS Therapy Development Institute / ALS Therapy Development Institute / /

IndustryTerm

biotechnology / potential efficacy screening protocols / health care services / /

MedicalCondition

progressive neurodegenerative disease / Alzheimer’s Disease / Lou Gehrig’s disease / disease / neurodegenerative disease / several neurodegenerative diseases / neuromuscular diseases / ALS / dementias / amyotrophic lateral sclerosis / traumatic brain injury / /

Organization

Alzheimer’s Drug Discovery Foundation / Washington University in St. Louis / Muscular Dystrophy Association / Drug Development Foundation / ALS Therapy Development Institute / Association for Frontotemporal Degeneration / /

Person

Robert Baloh / Steve Perrin / Robert Brown / Howard Fillit / Lou Gehrig / Mark Gurney / Teepu Siddique / Robert A. Goldstein / /

Position

CEO / executive director / mouse model / /

ProvinceOrState

Massachusetts / /

Technology

neuroscience / Drug Discovery / biotechnology / gene expression / DNA Binding / potential efficacy screening protocols / Drug Development / /

URL

www.AlzDiscovery.org / www.als.net / www.mda.org / /

SocialTag